ALNYALNYLAM PHARMACEUTICALS, INC.vs its industry peers
A metric-by-metric comparison of ALNYLAM PHARMACEUTICALS, INC. against iShares Biotechnology ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNYThis | $31.9B#11 | 41.5x#6 | 23.5x#9 | 8.6x#6 | 65.2%#2 | 212.8%#4 | 13.5%#8 | 23.2%#4 | 150.5%#1 | — | -48.3%#10 | — |
| VRTX | $130.4B#4 | 30.0x#4 | 6.4x#3 | 10.9x#7 | 8.9%#7 | 838.1%#3 | 34.8%#2 | 19.5%#6 | 25.0%#5 | — | 31.0%#7 | — |
| AMGN | $203.1B#2 | 23.3x#3 | 17.4x#8 | 5.5x#3 | 10.0%#6 | 88.5%#7 | 24.7%#6 | 66.0%#2 | 15.1%#7 | — | 40.3%#5 | 2.5%#1 |
| GILD | $181.4B#3 | — | 15.3x#6 | 6.2x#4 | 2.4%#8 | 1672.9%#2 | 34.0%#3 | 71.9%#1 | 26.7%#4 | — | 32.9%#6 | 2.2%#2 |
| ARGX | $60.6B#5 | — | — | 1705.6x#11 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | 29.4%#8 | — |
| NTRA | $50.6B#7 | — | 27.8x#10 | 21.9x#8 | 35.9%#4 | -9.3%#10 | -13.4%#10 | -11.4%#9 | -18.0%#9 | — | — | — |
| RVMD | $43.9B#8 | — | 16.9x#7 | — | — | -88.5%#12 | — | -43.4%#11 | — | — | 343.5%#2 | — |
| BIIB | $31.9B#10 | 23.2x#2 | 2.2x#1 | 3.2x#1 | 2.2%#9 | -20.8%#11 | 28.7%#5 | 8.7%#7 | 13.0%#8 | 4#3 | 50.8%#4 | — |
| ILMN | $33.6B#9 | 41.5x#5 | 11.8x#5 | 7.7x#5 | -0.7%#10 | 169.5%#5 | 18.6%#7 | 30.0%#3 | 22.0%#6 | 7#1 | 120.1%#3 | — |
| MRNA | $57.4B#6 | — | 8.5x#4 | 29.5x#9 | -39.9%#11 | 20.8%#9 | -158.1%#11 | -41.7%#10 | -54.6%#10 | — | 501.9%#1 | — |
| ONC | $511.7B#1 | 805.0x#7 | 98.9x#11 | 95.8x#10 | 40.2%#3 | 144.5%#6 | 8.4%#9 | 5.5%#8 | 29.9%#3 | 6#2 | 4.2%#9 | — |
| INCY | $24.3B#12 | 17.2x#1 | 4.3x#2 | 4.7x#2 | 21.2%#5 | 3846.9%#1 | 29.5%#4 | 22.9%#5 | 49.0%#2 | — | — | — |
Peer set: top holdings of IBB (iShares Biotechnology ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice